As of June 2026, according to Globus Medical's current financial statements, the company's 12-month EPS is $4.35. For the year 2025, the company recorded an earnings per share (EPS) of $3.98, which marks an increase compared to its EPS of $0.76 in 2024. Globus Medical's earnings per share for the quarterly report ending on Mar 31, 2026 reached $0.92.
The annual EPS for the year 2025 was $3.98, an increase of 423.7% from $0.76 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $0.92, showing a 67.3% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $4.35. For the year 2024, the yearly earnings per share was $0.76, marking a decrease of 30.3% from 2023.
Globus Medical has registered an increase in EPS of 67.3% during the last 12 months (YoY, quarterly). In the last three years, GMED recorded an average annual EPS growth rate of 28.2%. Globus Medical had an average annual EPS growth rate of 30.8% during the last 5 years. Across the last decade, GMED had an average annual EPS growth of 12.8%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| GMED Globus Medical Inc | 18.26 | 423.7% | 28.2% | 30.8% |
| SYK Stryker Corp | 35.26 | 8% | 10.9% | 14.8% |
| OFIX Orthofix Medical Inc | N/A | 29.4% | N/A | N/A |
| ATEC Alphatec Holdings Inc | N/A | 15% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.